United States ALL Vaccine Market Report 2017

  • Apr 2017
  • By QY Research
  • 126 pages
  • Report Id: 90169

United States ALL Vaccine Market Report 2017

  • Apr 2017
  • By QY Research
  • 126 pages
  • Report Id: 90169
The global ALL Vaccine market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

United States plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the ALL Vaccine development status and future trend in United States, focuses on top players in United States, also splits ALL Vaccine by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in United States market include Pfizer, Inc., Glaxosmithkline, PLC., Merck & Co., Inc., Novarits, Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Inc., Johnson & Johnson, Medimmune, LLC. (A Subsidiary of Astrazeneca), Astellas Pharma Inc., Mitsubishi Tanabe, Dynavax Technologies, Novavax


Geographically, this report splits the United States market into six regions,
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest


On the basis of product, the ALL Vaccine market is primarily split into
Vaccinia
Measles, mumps, rubella
Varicella
Influenza
Rotavirus
Zoster
Yellow Fever
Polio
Hepatitis A
Rabies
BCG
Diphtheria, tetanus
Hepatitis B
Haemophilus influenzae type b
Pertussis
Human papillomavirus
Meningococcal
Pneumococcal


On the basis on the end users/applications, this report covers
For Adult
For Child


Table of Contents

United States ALL Vaccine Market Report 2017
1 ALL Vaccine Overview
1.1 Product Overview and Scope of ALL Vaccine
1.2 Classification of ALL Vaccine by Product Category
1.2.1 United States ALL Vaccine Sales (K Units) Comparison by Types (2012-2022)
1.2.2 United States ALL Vaccine Sales (K Units) Market Share by Types (Product Category) in 2016
1.2.3 Vaccinia
1.2.4 Measles, mumps, rubella
1.2.5 Varicella
1.2.6 Influenza
1.2.7 Rotavirus
1.2.8 Zoster
1.2.9 Yellow Fever
1.2.10 Polio
1.2.11 Hepatitis A
1.2.12 Rabies
1.2.13 BCG
1.2.14 Diphtheria, tetanus
1.2.15 Hepatitis B
1.2.16 Haemophilus influenzae type b
1.2.17 Pertussis
1.2.18 Human papillomavirus
1.2.19 Meningococcal
1.2.20 Pneumococcal
1.3 United States ALL Vaccine Market by Applications/End Users
1.3.1 United States ALL Vaccine Sales (K Units) and Market Share Comparison by Applications (2012-2022)
1.3.2 For Adult
1.3.3 For Child
1.4 United States ALL Vaccine Market by Regions
1.4.1 United States ALL Vaccine Market Size (Million USD) Comparison by Regions (2012-2022)
1.4.2 The West ALL Vaccine Status and Prospect (2012-2022)
1.4.3 Southwest ALL Vaccine Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic ALL Vaccine Status and Prospect (2012-2022)
1.4.5 New England ALL Vaccine Status and Prospect (2012-2022)
1.4.6 The South of US ALL Vaccine Status and Prospect (2012-2022)
1.4.7 The Midwest ALL Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Sales and Revenue) of ALL Vaccine (2012-2022)
1.5.1 United States ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
1.5.2 United States ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
2 United States ALL Vaccine Market Competition by Players/Manufacturers
2.1 United States ALL Vaccine Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 United States ALL Vaccine Revenue and Share by Players/Manufacturers (2012-2017)
2.3 United States ALL Vaccine Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 United States ALL Vaccine Market Competitive Situation and Trends
2.4.1 United States ALL Vaccine Market Concentration Rate
2.4.2 United States ALL Vaccine Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Manufacturers ALL Vaccine Manufacturing Base Distribution, Sales Area, Product Types
3 United States ALL Vaccine Sales and Revenue by Regions (2012-2017)
3.1 United States ALL Vaccine Sales (K Units) and Market Share by Regions (2012-2017)
3.2 United States ALL Vaccine Revenue (Million USD) and Market Share by Regions (2012-2017)
3.3 United States ALL Vaccine Price (USD/Unit) by Regions (2012-2017)
4 United States ALL Vaccine Sales and Revenue by Type/ Product Category (2012-2017)
4.1 United States ALL Vaccine Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 United States ALL Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 United States ALL Vaccine Price (USD/Unit) by Type (2012-2017)
4.4 United States ALL Vaccine Sales Growth Rate (%) (%) by Type (2012-2017)
5 United States ALL Vaccine Sales by Application (2012-2017)
5.1 United States ALL Vaccine Sales (K Units) and Market Share by Applications (2012-2017)
5.2 United States ALL Vaccine Sales Growth Rate (%) (%) by Applications (2012-2017)
5.3 Market Drivers and Opportunities
6 United States ALL Vaccine Players/Manufacturers Profiles and Sales Data
6.1 Pfizer, Inc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 ALL Vaccine Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Glaxosmithkline, PLC.
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 ALL Vaccine Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Glaxosmithkline, PLC. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merck & Co., Inc.
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 ALL Vaccine Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck & Co., Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Novarits
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 ALL Vaccine Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novarits ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Sanofi Pasteur
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 ALL Vaccine Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sanofi Pasteur ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.5.4 Main Business/Business Overview
6.6 CSL Limited
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 ALL Vaccine Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 CSL Limited ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Emergent Biosolutions, Inc.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 ALL Vaccine Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Emergent Biosolutions, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Johnson & Johnson
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 ALL Vaccine Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Johnson & Johnson ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Medimmune, LLC. (A Subsidiary of Astrazeneca)
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 ALL Vaccine Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Astellas Pharma Inc.
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 ALL Vaccine Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Astellas Pharma Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Mitsubishi Tanabe
6.12 Dynavax Technologies
6.13 Novavax
7 ALL Vaccine Manufacturing Cost Analysis
7.1 ALL Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of ALL Vaccine
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 ALL Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of ALL Vaccine Major Players/Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States ALL Vaccine Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 United States ALL Vaccine Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 United States ALL Vaccine Sales (K Units) Forecast by Type (2017-2022)
11.3 United States ALL Vaccine Sales (K Units) Forecast by Application (2017-2022)
11.4 United States ALL Vaccine Sales (K Units) Forecast by Regions (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Tables and Figures

Figure Global and United States Market Size (Million USD) Comparison 2012-2022
Table United States ALL Vaccine Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table United States ALL Vaccine Sales (K Units) by Application (2016-2022)
Figure Product Picture of ALL Vaccine
Table United States ALL Vaccine Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure United States ALL Vaccine Sales Volume Market Share by Types (Product Category) in 2016
Figure Vaccinia Product Picture
Figure Measles, mumps, rubella Product Picture
Figure Varicella Product Picture
Figure Influenza Product Picture
Figure Rotavirus Product Picture
Table United States ALL Vaccine Sales (K Units) Comparison by Applications (2012-2022)
Figure United States Sales Market Share (%) of ALL Vaccine by Applications in 2016
Figure For Adult Examples
Figure For Child Examples
Figure United States ALL Vaccine Market Size (Million USD) Comparison by Regions (2012-2022)
Figure The West ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
Figure United States ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Table United States ALL Vaccine Sales of Key Players/Manufacturers (2012-2017)
Table United States ALL Vaccine Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 United States ALL Vaccine Sales Share (%) by Players/Manufacturers
Figure 2017 United States ALL Vaccine Sales Share (%) by Players/Manufacturers
Table United States ALL Vaccine Revenue by Players/Manufacturers (2012-2017)
Table United States ALL Vaccine Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 United States ALL Vaccine Revenue Market Share (%) by Players/Manufacturers
Figure 2017 United States ALL Vaccine Revenue Market Share (%) by Players/Manufacturers
Table United States Market ALL Vaccine Average Price of Key Players/Manufacturers (2012-2017)
Figure United States Market ALL Vaccine Average Price of Key Players/Manufacturers in 2016
Figure United States ALL Vaccine Market Share of Top 3 Players/Manufacturers
Figure United States ALL Vaccine Market Share of Top 5 Players/Manufacturers
Table United States Players/Manufacturers ALL Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Manufacturers ALL Vaccine Product Category
Table United States ALL Vaccine Sales (K Units) by Regions (2012-2017)
Table United States ALL Vaccine Sales Share (%) by Regions (2012-2017)
Figure United States ALL Vaccine Sales Share (%) by Regions (2012-2017)
Figure United States ALL Vaccine Sales Market Share (%) by Regions in 2016
Table United States ALL Vaccine Revenue (Million USD) and Market Share by Regions (2012-2017)
Table United States ALL Vaccine Revenue Market Share (%) by Regions (2012-2017)
Figure United States ALL Vaccine Revenue Market Share (%) by Regions (2012-2017)
Figure United States ALL Vaccine Revenue Market Share (%) by Regions in 2016
Table United States ALL Vaccine Price (USD/Unit) by Regions (2012-2017)
Table United States ALL Vaccine Sales (K Units) by Type (2012-2017)
Table United States ALL Vaccine Sales Share (%) by Type (2012-2017)
Figure United States ALL Vaccine Sales Share (%) by Type (2012-2017)
Figure United States ALL Vaccine Sales Market Share (%) by Type in 2016
Table United States ALL Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States ALL Vaccine Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of ALL Vaccine by Type (2012-2017)
Figure Revenue Market Share of ALL Vaccine by Type in 2016
Table United States ALL Vaccine Price (USD/Unit) by Types (2012-2017)
Figure United States ALL Vaccine Sales Growth Rate (%) (%) by Type (2012-2017)
Table United States ALL Vaccine Sales (K Units) by Applications (2012-2017)
Table United States ALL Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure United States ALL Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure United States ALL Vaccine Sales Market Share (%) by Applications in 2016
Table United States ALL Vaccine Sales Growth Rate (%) (%) by Applications (2012-2017)
Figure United States ALL Vaccine Sales Growth Rate (%) by Applications (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Pfizer, Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Pfizer, Inc. ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Pfizer, Inc. ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Glaxosmithkline, PLC. Basic Information List
Table Glaxosmithkline, PLC. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Glaxosmithkline, PLC. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Glaxosmithkline, PLC. ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Glaxosmithkline, PLC. ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Merck & Co., Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Merck & Co., Inc. ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Merck & Co., Inc. ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Novarits Basic Information List
Table Novarits ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Novarits ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Novarits ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Novarits ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Sanofi Pasteur ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Sanofi Pasteur ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Sanofi Pasteur ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure CSL Limited ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure CSL Limited ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure CSL Limited ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Emergent Biosolutions, Inc. Basic Information List
Table Emergent Biosolutions, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Emergent Biosolutions, Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Emergent Biosolutions, Inc. ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Emergent Biosolutions, Inc. ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Johnson & Johnson ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Johnson & Johnson ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Johnson & Johnson ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Medimmune, LLC. (A Subsidiary of Astrazeneca) Basic Information List
Table Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Astellas Pharma Inc. Basic Information List
Table Astellas Pharma Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Astellas Pharma Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Astellas Pharma Inc. ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Astellas Pharma Inc. ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of ALL Vaccine
Figure Manufacturing Process Analysis of ALL Vaccine
Figure ALL Vaccine Industrial Chain Analysis
Table Raw Materials Sources of ALL Vaccine Major Players/Manufacturers in 2015
Table Major Buyers of ALL Vaccine
Table Distributors/Traders List
Figure United States ALL Vaccine Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure United States ALL Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States ALL Vaccine Price (USD/Unit) Trend Forecast (2017-2022)
Table United States ALL Vaccine Sales (K Units) Forecast by Type (2017-2022)
Figure United States ALL Vaccine Sales (K Units) Forecast by Type (2017-2022)
Figure United States ALL Vaccine Sales Volume Market Share Forecast by Type in 2022
Table United States ALL Vaccine Sales (K Units) Forecast by Application (2017-2022)
Figure United States ALL Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
Figure United States ALL Vaccine Sales Volume Market Share Forecast by Application in 2022
Table United States ALL Vaccine Sales (K Units) Forecast by Regions (2017-2022)
Table United States ALL Vaccine Sales Volume Share Forecast by Regions (2017-2022)
Figure United States ALL Vaccine Sales Volume Share Forecast by Regions (2017-2022)
Figure United States ALL Vaccine Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources